MHC class I-presented tumor antigen appraisable for T-cell responses against ovarian cancer. Bangladesh J Pharmacol [Internet]. 2015 Jul. 1 [cited 2026 Jun. 29];10(3):524-8. Available from: https://www.banglajol.info/index.php/BJP/article/view/23076